{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:45:43Z","timestamp":1791474343530,"version":"4.3.4"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2011,6,28]],"date-time":"2011-06-28T00:00:00Z","timestamp":1309219200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0001151","type":"journal-article","created":{"date-parts":[[2011,6,28]],"date-time":"2011-06-28T16:38:10Z","timestamp":1309279090000},"page":"e1151","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":274,"title":["SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis"],"prefix":"10.1371","volume":"5","author":[{"given":"Robert T.","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakela","family":"Nare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Wring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daitao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Sligar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew X.","family":"Jenks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Noe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tana S.","family":"Bowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke T.","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Rewerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Gaukel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Parham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Randolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Beaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus J.","family":"Bacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Yarlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob J.","family":"Plattner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Freund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Akama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-K.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reto","family":"Brun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Scandale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Don","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,6,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1590\/S0074-02761999000200018","article-title":"Therapy of human African trypanosomiasis: current situation.","volume":"94","author":"J Atouguia","year":"1999","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bjp.0707354","article-title":"Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.","volume":"152","author":"MP Barrett","year":"2007","journal-title":"Br J Pharmacol"},{"key":"ref3","first-page":"71","article-title":"Human African trypanosomiasis (sleeping sickness): epidemiological update.","volume":"81","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1371\/journal.pmed.0050055","article-title":"Eliminating Human African Trypanosomiasis: Where Do We Stand and What Comes Next?","volume":"5","author":"PP Simarro","year":"2008","journal-title":"PLoS Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1371\/journal.pntd.0000333","article-title":"The Burden of Human African Trypanosomiasis.","volume":"2","author":"EM F\u00e8vre","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/13550280802282934","article-title":"Traversal of human and animal trypanosomes across the blood-brain barrier.","volume":"14","author":"DJ Grab","year":"2008","journal-title":"J Neurovirol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.pt.2005.08.026","article-title":"Chemotherapy of trypanosomiases and leishmaniasis.","volume":"21","author":"SL Croft","year":"2005","journal-title":"Trends Parasitol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1017\/S1462399409001252","article-title":"Trypanocidal drugs: mechanisms, resistance and new targets.","volume":"11","author":"SR Wilkinson","year":"2009","journal-title":"Expert Rev Mol Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1371\/journal.pntd.0000064","article-title":"Nifurtimox plus Eflornithine for late-stage sleeping sickness in Uganda: a case series.","volume":"1","author":"F Checchi","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/522982","article-title":"Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.","volume":"45","author":"G Priotto","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(09)61163-6","article-title":"NECT trial: more than a small victory over sleeping sickness.","volume":"374","author":"J Opigo","year":"2009","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.","volume":"374","author":"G Priotto","year":"2009","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e720","DOI":"10.1371\/journal.pntd.0000720","article-title":"NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness.","volume":"4","author":"O Yun","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nature08893","article-title":"N-myristoyltransferase inhibitors as new leads to treat sleeping sickness.","volume":"464","author":"JA Frearson","year":"2010","journal-title":"Nature"},{"key":"ref15","article-title":"State of the Art in African Trypanosome Drug Discovery.","author":"RTNB Jacobs","year":"2010"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1021\/ml100013s","article-title":"Discovery of Novel Benzoxaborole-Based Potent Antitrypanosomal Agents.","volume":"1","author":"D Ding","year":"2010","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1128\/AAC.00498-10","article-title":"Discovery of Novel Orally Bioavailable Oxaborole 6-Carboxamides That Demonstrate Cure in a Murine Model of Late-Stage Central Nervous System African Trypanosomiasis.","volume":"54","author":"B Nare","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1128\/AAC.40.6.1448","article-title":"In vivo trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors.","volume":"40","author":"CJ Bacchi","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","first-page":"147","article-title":"Relapsed parasitaemia following chemotherapy of chronic T. brucei infections in mice and its relation to cerebral trypanosomes.","volume":"7","author":"FW Jennings","year":"1983","journal-title":"Contrib Microbiol Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2307\/3282883","article-title":"Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers.","volume":"75","author":"H Hirumi","year":"1989","journal-title":"J Parasitol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/j.1460-2075.1985.tb03772.x","article-title":"Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense.","volume":"4","author":"T Baltz","year":"1985","journal-title":"EMBO J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0001-706X(97)00079-X","article-title":"The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro.","volume":"68","author":"B Raz","year":"1997","journal-title":"Acta Trop"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0163-7258(88)90025-3","article-title":"Human drug metabolism in vitro.","volume":"37","author":"PH Beaune","year":"1988","journal-title":"Pharmacol Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-3565(24)29270-3","article-title":"Rational use of in vitro P-glycoprotein assays in drug discovery.","volume":"299","author":"JW Polli","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1002\/jps.20166","article-title":"In vitro absorption and secretory quotients: practical criteria derived from a study of 331 compounds to assess for the impact of P-glycoprotein-mediated efflux on drug candidates.","volume":"93","author":"VE Thiel-Demby","year":"2004","journal-title":"J Pharm Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1021\/mp800122b","article-title":"Biopharmaceutics classification system: validation and learnings of an in vitro permeability assay.","volume":"6","author":"VE Thiel-Demby","year":"2009","journal-title":"Mol Pharm"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1023\/A:1025001131513","article-title":"Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.","volume":"20","author":"MD Troutman","year":"2003","journal-title":"Pharm Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/1087057106295897","article-title":"Optimizing classification of drug-drug interaction potential for CYP450 isoenzyme inhibition assays in early drug discovery.","volume":"12","author":"BF Krippendorff","year":"2007","journal-title":"J Biomol Screen"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/AAC.48.2.369-377.2004","article-title":"Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC.","volume":"48","author":"M Mueller","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/AAC.00604-06","article-title":"Semimechanistic pharmacokinetic\/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments.","volume":"51","author":"EI Nielsen","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4269\/ajtmh.1987.36.46","article-title":"Effects of the ornithine decarboxylase inhibitors DL-alpha-difluoromethylornithine and alpha-monofluoromethyldehydroornithine methyl ester alone and in combination with suramin against Trypanosoma brucei brucei central nervous system models.","volume":"36","author":"CJ Bacchi","year":"1987","journal-title":"Am J Trop Med Hyg"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1128\/AAC.42.10.2718","article-title":"Antitrypanosomal Activity of a New Triazine Derivative, SIPI 1029, In Vitro and in Model Infections.","volume":"42","author":"CJ Bacchi","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0092-8674(95)90340-2","article-title":"A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel.","volume":"81","author":"MC Sanguinetti","year":"1995","journal-title":"Cell"},{"key":"ref34","first-page":"H2534","article-title":"Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride.","volume":"273","author":"S Mohammad","year":"1997","journal-title":"Am J Physiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0006-3495(98)77782-3","article-title":"Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature.","volume":"74","author":"Z Zhou","year":"1998","journal-title":"Biophys J"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0165-1161(75)90046-1","article-title":"Methods for detecting carcinogens and mutagens with the Salmonella\/mammalian-microsome mutagenicity test.","volume":"31","author":"BN Ames","year":"1975","journal-title":"Mutat Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000079137","article-title":"Steady-state brain concentrations of antihistamines in rats: interplay of membrane permeability, P-glycoprotein efflux and plasma protein binding.","volume":"72","author":"KM Mahar Doan","year":"2004","journal-title":"Pharmacology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF02783146","article-title":"A comparative review of the pharmacokinetics of boric acid in rodents and humans.","volume":"66","author":"FJ Murray","year":"1998","journal-title":"Biol Trace Elem Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0890-6238(97)00067-1","article-title":"Blood boron concentrations in pregnant rats fed boric acid throughout gestation.","volume":"11","author":"CJ Price","year":"1997","journal-title":"Reprod Toxicol"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0001151","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T15:10:01Z","timestamp":1741273801000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0001151"}},"subtitle":[],"editor":[{"given":"Jennifer","family":"Keiser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,6,28]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0001151","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.11983957.13110056","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.11983957.13921054","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,28]]}}}